Related references
Note: Only part of the references are listed.The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation
Mehdi Hamadani et al.
BLOOD (2008)
Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity
Robert Zeiser et al.
BLOOD (2007)
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukeryiia
Ronjon Chakraverty et al.
BLOOD (2007)
Rituximab for steroid-refractory chronic graft-versus-host disease
Corey Cutler et al.
BLOOD (2006)
Differential effects of statins on relevant functions of human monocyte-derived dendritic cells
Atilla Yilmaz et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease
A Hori et al.
TRANSPLANTATION (2005)
Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application
MS von Bergwelt-Baildon et al.
BLOOD (2002)
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
G Weitz-Schmidt et al.
NATURE MEDICINE (2001)
Share Paper
